Glenmark Pharmaceuticals Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Sub: Glenmark Pharmaceuticals enters into an Exclusive Licensing Agreement with Yuhan Corporation for commercializing Investigational Seasonal Allergic Rhinitis Nasal Spray Ryaltris in South Korea

Dear Sir,

With reference to the subject mentioned above, kindly find attached media release which is self explanatory.

Request you to kindly take the same on record.

Thanking you,

Pdf Link: Glenmark Pharmaceuticals Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Source : BSE - www.bseindia.com

Published on January 10, 2019

Related

This article is closed for comments.
Please Email the Editor